![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|10|2|147-154
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.10, Iss.2, 2010-03, pp. : 147-154
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Endocrine Disruptor Risk Characterization: An EPA Perspective
Regulatory Toxicology and Pharmacology, Vol. 26, Iss. 1, 1997-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacological Modulation of Arterial Stiffness
Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. :